Israel HIV AIDS Industry Outlook 2018

See how Israel HIV AIDS performed compared to key markets such as South Africa, Nigeria and Mozambique.

Key Market Indicators

In 2018, the HIV/AIDS prevalence rate in Israel among those aged 0-14 remained stable compared to 2017, at roughly 100 people. This rate has remained steady since 1995. Globally, the Netherlands had the highest rate among this age group at 100 people, followed by Nigeria, Mozambique and Tanzania in second, third and fourth place respectively.

Israel HIV AIDS Market Data and Forecasts

How much will Israel HIV AIDS Market grow?

Forecast: Incidence of Tuberculosis (Including HIV-Positive Cases) in Israel
Forecast: Hospital Discharges for HIV Cases in Israel

Other Top Countries about HIV AIDS